Influence of CAR T-cell expansion and persistence in the peripheral blood on CAR T-cell therapy efficacy and adverse events in multiple myeloma

• by M. Boettger, P. Sauerborn, G. Ihorst, S. Ochoa, M. Sieder, C. Greil, M. Engelhardt, R. Wäsch

• November 7, 2026

A precision T-cell therapy stalls treatment-resistant cancers in clinical trial

• October 23, 2026

Naive-Like T Cells Linked to CAR T Durability

Higher proportions of less-differentiated T cells were associated with longer progression-free survival in a 783-patient lymphoma analysis

• November 4, 2026

• 3 min

Two ‘forever chemicals’ associated with higher risk of aggressive breast cancer in NIH analysis

• by Assistant Secretary for Public Affairs (ASPA)

• November 5, 2026